GSK plc (LON:GSK) Receives Average Recommendation of “Moderate Buy” from Analysts

Shares of GSK plc (LON:GSK) have been given an average recommendation of “Moderate Buy” by the seven ratings firms that are currently covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and five have issued a buy rating on the company. The average twelve-month price target among brokers that have covered the stock in the last year is GBX 1,805.83 ($22.10).

Several analysts have recently commented on GSK shares. JPMorgan Chase & Co. restated an “underweight” rating on shares of GSK in a research note on Tuesday, January 7th. Berenberg Bank cut their price target on GSK from GBX 1,820 ($22.27) to GBX 1,600 ($19.58) and set a “buy” rating on the stock in a report on Friday, November 29th.

Insider Buying and Selling at GSK

In other GSK news, insider Jonathan Symonds acquired 7,150 shares of the stock in a transaction that occurred on Wednesday, October 30th. The shares were bought at an average price of GBX 1,394 ($17.06) per share, for a total transaction of £99,671 ($121,966.47). Insiders purchased 8,658 shares of company stock valued at $11,950,792 in the last quarter. 1.61% of the stock is currently owned by corporate insiders.

GSK Stock Down 1.1 %

Shares of LON:GSK opened at GBX 1,330.06 ($16.28) on Tuesday. GSK has a 1 year low of GBX 1,282.50 ($15.69) and a 1 year high of GBX 1,823.50 ($22.31). The company has a debt-to-equity ratio of 123.04, a current ratio of 0.82 and a quick ratio of 0.73. The business’s 50-day moving average is GBX 1,348.92 and its 200-day moving average is GBX 1,475.52. The company has a market capitalization of £54.27 billion, a price-to-earnings ratio of 1,177.04, a P/E/G ratio of 1.24 and a beta of 0.31.

GSK Announces Dividend

The business also recently disclosed a dividend, which was paid on Thursday, January 9th. Investors of record on Thursday, November 14th were paid a dividend of GBX 15 ($0.18) per share. The ex-dividend date was Thursday, November 14th. This represents a dividend yield of 1.03%. GSK’s payout ratio is 5,309.73%.

GSK Company Profile

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.